Climb Bio, Inc. CLYM Short- term Investments
Short- term Investments at other companies
Other financials
Where this comes from
Reported directly by Climb Bio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:MarketableSecuritiesCurrent.
The official record: Climb Bio, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Climb Bio, Inc.'s short- term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Climb Bio, Inc.'s short- term investments?
- Climb Bio, Inc. (CLYM) reported short- term investments of $101.21M in Q1 2026.
- How has Climb Bio, Inc.'s short- term investments changed year-over-year?
- Climb Bio, Inc.'s short- term investments increased by 46.6% year-over-year, from $69.04M to $101.21M.